Transcatheter aortic valve implantation: current status and future perspectives

TJ Cahill, M Chen, K Hayashida, A Latib… - European heart …, 2018 - academic.oup.com
In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

2018 AATS/ACC/SCAI/STS expert consensus systems of care document: operator and institutional recommendations and requirements for transcatheter aortic valve …

JE Bavaria, CL Tommaso, RG Brindis, JD Carroll… - Journal of the American …, 2019 - jacc.org
Registry data that shows a clinically meaningful association of higher mortality and other
major complications with site annual volume below the recommended threshold of 50 …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint …

Writing Committee Members, CM Otto… - Journal of the American …, 2021 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American …

CM Otto, RA Nishimura, RO Bonow… - Journal of the American …, 2021 - jacc.org
Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients

MJ Mack, MB Leon, VH Thourani… - … England Journal of …, 2019 - Mass Medical Soc
Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement …

Procedural volume and outcomes for transcatheter aortic-valve replacement

S Vemulapalli, JD Carroll, MJ Mack, Z Li… - … England Journal of …, 2019 - Mass Medical Soc
Background During the introduction of transcatheter aortic-valve replacement (TAVR) in the
United States, requirements regarding procedural volume were mandated by the Centers for …

The Vancouver 3M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume …

DA Wood, SB Lauck, JA Cairns, KH Humphries… - Cardiovascular …, 2019 - jacc.org
Objectives The authors sought to prospectively determine the safety and efficacy of next-day
discharge using the Vancouver 3M (Multidisciplinary, Multimodality, but Minimalist) Clinical …

Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a …

RR Makkar, W Cheng, R Waksman, LF Satler… - The Lancet, 2020 - thelancet.com
Background Randomised trial data assessing the safety and efficacy of the self-expanding
intra-annular Portico transcatheter aortic valve system (Abbott Structural Heart, St Paul, MN …

Transcatheter aortic valve replacement in low-risk patients with bicuspid aortic valve stenosis

JK Forrest, B Ramlawi, GM Deeb, F Zahr… - JAMA …, 2021 - jamanetwork.com
Importance The outcomes of transcatheter aortic valve replacement (TAVR) in low-risk
patients with bicuspid aortic valve stenosis have not been studied in a large scale …

Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II

TM Nazif, J Moses, R Sharma, A Dhoble, J Rovin… - Cardiovascular …, 2021 - jacc.org
Abstract Objectives The REFLECT II (Randomized Evaluation of TriGuard 3 Cerebral
Embolic Protection After Transcatheter Aortic Valve Implantation) trial was designed to …